NASDAQ: SAVA - Cassava Sciences, Inc.

Доходность за полгода: -94.04%
Дивидендная доходность: 0.00%
Сектор: Healthcare

Новости
US opens criminal probe into pharma company over potential Alzheimer's drug fraud: report

19 ноября 22:48 US opens criminal probe into pharma company over potential Alzheimer's drug fraud: report